Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
1.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

7.8K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

13.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

6.2K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Notch Signaling Pathway03:14

Notch Signaling Pathway

6.8K
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Hippo signaling pathway in pediatric brain tumors: molecular mechanisms and therapeutic opportunities.

Cancer metastasis reviews·2026
Same author

Epigenetic Regulation of RUNX2 in Bone Mechanobiology.

Results and problems in cell differentiation·2026
Same author

Polycystin-1 Orchestrates Tumor Context-Dependent Mechanotransduction Programs Driving Epithelial-to-Mesenchymal Transition and Invasion in Solid Cancers.

International journal of biological sciences·2026
Same author

Serum Bilirubin as a Prognostic Factor in Lung Cancer.

Diagnostics (Basel, Switzerland)·2026
Same author

Targeting the MAPK Pathway in Brain Tumors: Mechanisms and Therapeutic Opportunities.

Cancers·2026
Same author

The Critical Role of Transcription Factor RUNX2 in Bone Mechanobiology.

Cells·2026

Related Experiment Video

Updated: Mar 21, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.7K

Deciphering signaling networks in osteosarcoma pathobiology.

Christos Adamopoulos1, Antonios N Gargalionis1, Efthimia K Basdra1

  • 1Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens 11527, Greece.

Experimental Biology and Medicine (Maywood, N.J.)
|May 19, 2016
PubMed
Summary

Osteosarcoma, a common childhood bone cancer, has seen little prognostic improvement, especially in metastatic cases. Understanding its complex molecular pathways is key to developing targeted treatments.

Keywords:
Osteosarcomaactivator protein-1mammalian target of rapamycinmechanotransductionnuclear factor-κBsignal transduction

More Related Videos

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.4K
A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.7K

Related Experiment Videos

Last Updated: Mar 21, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.7K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.4K
A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.7K

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Osteosarcoma is the most common primary bone tumor in children and adolescents.
  • Prognosis for osteosarcoma patients, particularly with metastatic disease, has seen limited improvement.
  • High tumor heterogeneity and genomic instability characterize osteosarcoma, complicating treatment strategies.

Purpose of the Study:

  • To review recent advances in understanding the molecular mechanisms of osteosarcoma progression and metastasis.
  • To discuss critical signaling pathways implicated in osteosarcoma pathobiology.
  • To explore potential novel therapeutic targets for patient-tailored treatments.

Main Methods:

  • Literature review of recent studies on osteosarcoma molecular mechanisms.
  • Analysis of signaling pathways involved in osteosarcoma development and spread.
  • Discussion of current research on therapeutic targets.

Main Results:

  • Genomic instability and gene alterations are common in osteosarcoma but lack a consistent pattern.
  • Several key signal transduction pathways (RANK, Wnt, Notch, PI3K/Akt/mTOR, mechanotransduction) are implicated in osteosarcoma.
  • These pathways represent potential targets for novel therapeutic interventions.

Conclusions:

  • A deeper understanding of osteosarcoma's molecular complexity is crucial for improving patient outcomes.
  • Targeting specific signaling pathways holds promise for developing more effective, personalized treatments for osteosarcoma.
  • Further research into these pathways could lead to breakthroughs in managing metastatic osteosarcoma.